Thermo Scientific issues software update after confirming bug in its bioequivalence data platform
Thermo Fisher Scientific has issued a letter to users of its Kinetica technology software confirming discrepancies in its bioequivalence data.
Archives for November 4, 2014
dispatches from AAPS
Breaking Ad: Can virus-delivered gene therapy help meth addicts quit?
Addicts struggling to kick a meth habit could be helped by gene therapy according to the team behind a US National Institutes of Health funded project.
Sterigenics buys amid speculation PE backer is looking to offload
Sterigenics International has bought Italian gamma-ray sterilisation firm Gammarad in a deal that comes amid rumors that private equity owner GTCR is looking to offload the Illinois-based contractor.
Golden spear: a thorn in Big Pharma’s ED business in China?
A generic version of Viagra launched in China contains the same amount of sildenafil citrate for a fraction of the price according to manufacturer Guangzhou Baiyuanshan Pharmaceutical Holdings (GBPH).
Dispatches from AAPS
US FDA offers more perspective on real-time release testing
As manufacturers begin to implement new RTRT (real-time release testing) models, a US FDA expert on the matter is offering additional help.
Dispatches from AAPS
Inhaler delivered peptide could prevent LDC deaths during childbirth, says GSK
Inhaled delivery of the labour inducing peptide oxytocin could help prevent millions of deaths in the lesser-developed countries (LDC), according to a GSK scientist.
Analyst says Covance execs are smart to back Lab Corp deal
Lab Corp will buy Covance for $6.1bn in a surprise deal that follows another quarter in which early phase gains were offset by underperformance in central labs.